Head & Neck Cancer

Latest News

From breast cancer to head and neck tumors, the 2025 ASCO Annual Meeting may feature a wide range of practice-changing data across cancer care.
ASCO 2025: The Presentations That May Shift the Cancer Care Paradigm

May 23rd 2025

From breast cancer to head and neck tumors, the 2025 ASCO Annual Meeting may feature a wide range of practice-changing data across cancer care.

Efti plus pembrolizumab demonstrated no new safety signals in the TACTI-003 trial.
Frontline Efti Combo Yields Meaningful Survival in PD-L1–Low HNSCC

May 8th 2025

Event-free survival events were observed in 37.5% of patients taking pembrolizumab vs 45.3% without among patients with resectable locally advanced HNSCC.
Perioperative Pembrolizumab Enhances Survival in Locally Advanced HNSCC

April 30th 2025

Data from the phase 3 AK105-304 study support the approval of penpulimab in this nasopharyngeal carcinoma population.
FDA Approves Penpulimab in Non-Keratinizing Nasopharyngeal Carcinoma

April 24th 2025

Advancing Biomedical Research on Salivary Antioxidants: Exploring the Significance in Oral Precancer and Cancer
Advancing Biomedical Research on Salivary Antioxidants: Exploring the Significance in Oral Precancer and Cancer

April 16th 2025

Video Interviews
Podcasts

More News